• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    BeiGene, Ontada Enter Strategic Oncology Alliance

    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    CMC Pharmaceuticals

    Qosina

    Baxter BioPharma Solutions

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    CMC Pharmaceuticals

    Qosina

    Baxter BioPharma Solutions

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Advanced Degrees

    Magic Mushrooms

    Giving new meaning to a fungus

    Related CONTENT
    • CPhI North America Event Info
    • Symbiosis Completes Successful MHRA Audit
    • Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease
    • CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    • Lakes BioScience Signs Agreement with Cytvia
    Kevin Ou2019Donnell, Contributing Editor03.06.13
    In the not-so-distant future, man’s gluttony for all things petrochemical will involuntarily end, forcing us to find alternatives to, well, just about all that we do, from how we heat our homes, to how we power our cars, and how to make everything we use — right down to this keyboard that I’m typing on. That’s the trouble with having an over-reliance on a single, finite source of energy.  We have exploited it beyond comprehension and with it we have compromised our health, the health of our planet and the future of our existence.

    It takes a massive amount of money and unrenewable energy to feed our estimated 300-million ton appetite of plastics consumed globally each year. About $20 billion dollars worth is spent on the creation and manufacture of the 5.5 million tons of expanded polystyrene (EPS) alone, used for such things as packaging, building products, insulation, and consumer goods. In our own short-sighted way, we conveniently cite the benefits of EPS rather than reflect on their long-term downsides, and polystyrene’s brief, benzene-producing life (a known carcinogen) typically ends up out of sight and out of mind — buried in a mountain of garbage somewhere, eternally occupying as much as 25% of a landfill’s overall mass. Consumer guilt results in an approximately 10% recycle rate, requiring yet more energy and more money to convert it into something else useful before it ultimately and permanently ends up in a garbage heap.

    In a perfect — yet admittedly inconceivable — post-petroleum world, wouldn’t it be nice if we could create high quality consumable packaging materials from waste products using a wide variety of organic, renewable, seemingly useless agricultural junk from anywhere around the world, like rice husks or cottonseed hulls, and by applying little or no energy to them, rely on nature to “grow” these products for us instead? Better yet, all this consumable packaging would be completely biodegradable, create no harmful gasses, byproducts, or leachable or extractible compounds. Instead they would return to the earth and enrich and regenerate the soil — like falling leaves on the forest floor.

    This is no alternate reality or B-movie science fiction plot: it’s already happening! It’s the dream of Eban Bayer, chief executive officer of an innovative little company called Ecovative (ecovativedesign.com) aptly situated on “Green Island” in the middle of the Hudson River among the tie-dyed and Berkenstocks crowd in upstate New York. Mr. Bayer and his team don’t actually make packaging — they grow it, with the help of mushrooms. Unlike traditional bioplastics whose feedstocks are typically food crops, Ecovative upcycles low value agricultural junk like plant stalks and seed husks, and inoculates them with mycelium, a fungal “root” network of threadlike cells.

    Like a blob of shredded garden compost, the feedstock is loaded and locked into a form (like a baking dish), and set aside for five to seven days. Then the magic happens. In the dark, and with no watering and no petrochemical inputs, the mycelium digest the agricultural byproducts, binding them into a solid structure. The mycelium act like natural, self-assembling glue. By using a broad range of feedstocks the developers are able to create diverse material properties, and tune their mushroom mixtures to adjust the density, strength, texture, appearance and performance characteristics of the materials they grow.

    How it works
    • Truckloads of agricultural byproducts that cannot be used for food or feed — and therefore have limited or no economic value — arrive from local farms. Utilizing only renewable, regional raw materials and low-tech manufacturing makes this an attractive solution adaptable to all regions of the world and may be of particular interest to those in developing countries.
    • Several types of farm waste are stored in large hoppers and then mixed in different ratios to meet specified material properties. A patented continuous steam pasteurization process cleans and prepares the blend of agricultural byproducts, ridding them of any mold or bacterial contamination that may have come from the field.
    • The pasteurized substrate is inoculated with mycelium, like planting the mushroom tissue. There are never any spores involved. This inoculated mixture is filled evenly into forms and loaded into pallet racks.
    • Then, nature’s proven multi-billion-year R&D process takes over. The mycelium grow rapidly, typically in less than a week, indoors, at ambient temperatures and ambient atmospheric pressure, and without the need for water, light, or human intervention. The mycelium do what mycelium have always done — they self-assemble by digesting the lignin and cellulose from the organic plant material to which they are attached, lengthening and expanding into a strong bio-composite until every nook and cranny of the mold forms are filled. Every cubic inch of material contains a matrix of eight miles of tiny mycelial fibers!
    • At the end of the process, the materials are popped out of their molds and put through a dehydration and heat-treating process to deactivate their growth. This final process ensures that there will never be any spores or allergen concerns and the finished parts are shipped to the customer.
    From beginning to end, the process aligns with nature’s recycling system. Composting, mulching, or land-filling the packaging made from this process are all environmentally sound options of disposal because the packaging is made of natural materials that belong in a healthy ecosystem. Even when plastic packaging is recycled (and it seldom is), the polymers degrade and are “down-cycled” into lower grade materials. Many bio-plastics have come under criticism because they require high temperature conditions found only in industrial composting facilities to break down. There is limited industrial composting capacity, and many of these facilities do not accept bio-plastics. Mycelium packaging is home-compostable, breaking down safely right in your own garden, and can be used to replace current EPS, EPP and EPE plastics.

    Current applications for this technology extend to structural insulated panels for buildings, acoustical tile, and protective packaging, as they contain similar R value and cushioning properties as their EPS counterparts, and are Class 1 fire rated. They also make a wine shipper (my personal favorite). Under development is a replacement for engineered wood, including particleboard and fiberboard. Mycelium is able to bind to natural and synthetic textiles such as burlap, hemp, jute, wood veneers, fiberglass, and carbon fiber, adhering naturally instead of using volatile chemical resins. In some cases, set times are less than 24 hours to reach full adhesion, which is comparable to polyurethane glues.

    Structural composites grown using Ecovative’s technology could soon be used to produce surfboards, furniture, and lightweight vehicle panels.

    I’m waiting to see who will be the first to use it as an insulated passive shipper. 

    References
    1. Data from Polystyrene Packaging Council (PSPC).

    Kevin O’Donnell is senior partner at Exelsius Cold Chain Management Consultancy – U.S. He is the former chair for the International Air Transport Association (IATA) Time & Temperature Task Force, a member of the USP Expert Committee on Packaging, Storage and Distribution, a temporary advisor and certified mentor to the World Health Organization (WHO), co-author of PDA Technical Report No. 39, and a member of the International Safe Transit Association (ISTA) Thermal Council. He blogs at www.clutchcargo.us. He can be reached at kevin.odonnell@exelsius.us.
    Related Searches
    • Development
    • Manufacturing
    • Filling
    • polymers
    Suggested For You
    CPhI North America Event Info CPhI North America Event Info
    Symbiosis Completes Successful MHRA Audit Symbiosis Completes Successful MHRA Audit
    Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Lakes BioScience Signs Agreement with Cytvia Lakes BioScience Signs Agreement with Cytvia
    Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
    Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues
    The Future of Clinical Trials The Future of Clinical Trials
    Gaston Salinas Botanical Solution Inc. Gaston Salinas Botanical Solution Inc.
    Trust, but Verify Trust, but Verify
    Let’s Get Genuine Let’s Get Genuine
    Raman Spectroscopy for Pharmaceutical Analysis & Quality Control Raman Spectroscopy for Pharmaceutical Analysis & Quality Control
    Spray Drying: A Proven Approach to Enhance the Solubility of APIs Spray Drying: A Proven Approach to Enhance the Solubility of APIs
    Inhaled Drug Delivery Trends Inhaled Drug Delivery Trends
    A Strong Partnership in Drug Development A Strong Partnership in Drug Development

    Related Live From Shows

    • CPhI North America Event Info

      CPhI North America Event Info

      ...
      04.21.22

    • Breaking News | Facilities | Industry News | Inspections
      Symbiosis Completes Successful MHRA Audit

      Symbiosis Completes Successful MHRA Audit

      Will expand facility at its Stirling, UK site with new storage and warehousing capability.
      09.16.21

    • Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
      Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease

      Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease

      Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.
      09.15.21


    • Biologics, Proteins, Vaccines
      CEO Spotlight: Gaston Salinas, Botanical Solution Inc.

      CEO Spotlight: Gaston Salinas, Botanical Solution Inc.

      QS-21 has become the ‘Gold Standard’ for human vaccine adjuvants and BSI is positioned to become a reliable supplier to the pharmaceutical market.
      Tim Wright, Editor, Contract Pharma 09.14.21

    • Breaking News | Collaborations & Alliances | Industry News
      Lakes BioScience Signs Agreement with Cytvia

      Lakes BioScience Signs Agreement with Cytvia

      Initiates the implementation of innovative workflows at Lakes BioScience’s factory in Cumbria.
      09.14.21

    Loading, Please Wait..
    Trending
    • Thermo Fisher Expands NY Cell Culture Media Manufacturing Site
    • Pfizer, Neurocrine Terminate Collaboration
    • Almac Invests $65M To Expand North American HQ
    • Catalent To Acquire Metrics Contract Services For $475M
    • Novavax Submits EUA For Protein-based COVID-19 Vax Booster
    Breaking News
    • Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    • BeiGene, Ontada Enter Strategic Oncology Alliance
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spartech Promotes Three Staff Members
    Elisabeth Lackner Named Chief Scientific Officer at Element Materials Technology
    Natech Plastics Purchases Three New Injection Molding Machines
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    BeiGene, Ontada Enter Strategic Oncology Alliance
    AskBio Appoints Clinical Ops Executives
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Body Shop Encourages Young People to Vote
    Weekly Recap: Howard Kaneff Dies, Keys Soulcare Adds SPF Skincare Offering & More
    Arkay Chairman Emeritus Howard Kaneff Has Died
    Happi

    Latest Breaking News From Happi

    In-Cosmetics Asia Returns to Bangkok to Deliver Look at Market Trends and Ingredient Innovations
    Perfect Corp. AI Skin Analysis Beauty SaaS Brand Console is Now HIPAA-Compliant
    Black-Owned Dinobi Detergent Uses Plant-Based Green Ingredients
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Pro Label Inc. installs first Mark Andy DSiQ hybrid press
    Gallus launches Gallus One inkjet label press
    Esko, Constantia Flexibles announce acquisitions and more
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Daio Paper Acquires Pet Care Products Manufacturer
    Honest Reports Increased Revenue
    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Achieves Strong Growth in Q2 2022
    Bone Void Fillers Market Growing at 6%
    ODT's Most-Read Stories This Week—Aug. 13
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login